Quarterly report · Q3
9265.TEDINET S100T8KZ
Period2023-06-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥45.4bn | 2023-06-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥58.2bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥41.7bn | 2022-06-01 → 2023-02-28 | Cons. | Net sales |
| Operating income | ¥830m | 2023-06-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | ¥895m | 2022-06-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥871m | 2023-06-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥936m | 2022-06-01 → 2023-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥721m | 2023-06-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | ¥333m | 2022-06-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥442m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥219m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥438m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | −¥3m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥25.6bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥24.6bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥22.5bn | at 2023-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥17.2bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥16.6bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.4bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥7.9bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥7.7bn | at 2023-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.5bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.8bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥173.23 | 2023-06-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.83 | 2023-12-01 → 2024-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.83 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.46 | 2022-06-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.44 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 32.8% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.2% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-06-01 → 2024-02-29 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-06-01 → 2024-02-29 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2024-02-29 | −¥844m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥209m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥209m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2023-06-01 → 2024-02-29 | ¥0 |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥2m |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥45.1bn |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥45.1bn |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2023-06-01 → 2024-02-29 | ¥0 |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥1.7bn |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥51m |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥51m |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥1m |
| —segment total | revenue | 2023-06-01 → 2024-02-29 | ¥45.4bn |
| —segment total | revenue external | 2023-06-01 → 2024-02-29 | ¥45.4bn |
| —segment total | revenue intersegment | 2023-06-01 → 2024-02-29 | ¥0 |
| —segment total | segment profit | 2023-06-01 → 2024-02-29 | ¥1.7bn |
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2023-02-28 | −¥11m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2023-02-28 | −¥11m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2023-02-28 | −¥690m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥211m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥211m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥0 |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥10m |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥41.5bn |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥41.5bn |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥11m |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥1.6bn |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥50m |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥50m |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥0 |
| —segment total | revenue | 2022-06-01 → 2023-02-28 | ¥41.7bn |
| —segment total | revenue external | 2022-06-01 → 2023-02-28 | ¥41.7bn |
| —segment total | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥11m |
| —segment total | segment profit | 2022-06-01 → 2023-02-28 | ¥1.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 366
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E33393-000MedicalMallReportableSegmentsMember | 0 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1586000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -690000000 | JPY |
| Operating income | Prior1YTDDuration | 895000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 45112000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 209000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalMallReportableSegmentsMember | 51000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 45373000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 45373000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalMallReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -0 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 45113000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 209000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalMallReportableSegmentsMember | 51000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 45374000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -0 | JPY |
| Net sales | CurrentYTDDuration | 45373000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 1671000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 2000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E33393-000MedicalMallReportableSegmentsMember | 1000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 1674000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -844000000 | JPY |
| Operating income | CurrentYTDDuration | 830000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)福岡財務支局長 | |
| Filing date cover page | FilingDateInstant | 2024-04-12 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第７期第３四半期(自 2023年12月１日 至 2024年２月29日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ヤマシタヘルスケアホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | YAMASHITA HEALTH CARE HOLDINGS,INC. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 執行役員 社長 山 下 尚 登 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)福岡市博多区下川端町２番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)092－402－2922（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 執行役員 吉 田 弘 幸 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)福岡市博多区下川端町２番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)092－402－2922（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 執行役員 吉 田 弘 幸 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E33393 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 92650 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ヤマシタヘルスケアホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | YAMASHITA HEALTH CARE HOLDINGS,INC. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |